Creatinine: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 66: Line 66:


==References==
==References==
{[reflist|2}}
{{reflist|2}}


{{SIB}}
{{SIB}}

Revision as of 17:12, 30 April 2012

Template:Chembox new

WikiDoc Resources for Creatinine

Articles

Most recent articles on Creatinine

Most cited articles on Creatinine

Review articles on Creatinine

Articles on Creatinine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Creatinine

Images of Creatinine

Photos of Creatinine

Podcasts & MP3s on Creatinine

Videos on Creatinine

Evidence Based Medicine

Cochrane Collaboration on Creatinine

Bandolier on Creatinine

TRIP on Creatinine

Clinical Trials

Ongoing Trials on Creatinine at Clinical Trials.gov

Trial results on Creatinine

Clinical Trials on Creatinine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Creatinine

NICE Guidance on Creatinine

NHS PRODIGY Guidance

FDA on Creatinine

CDC on Creatinine

Books

Books on Creatinine

News

Creatinine in the news

Be alerted to news on Creatinine

News trends on Creatinine

Commentary

Blogs on Creatinine

Definitions

Definitions of Creatinine

Patient Resources / Community

Patient resources on Creatinine

Discussion groups on Creatinine

Patient Handouts on Creatinine

Directions to Hospitals Treating Creatinine

Risk calculators and risk factors for Creatinine

Healthcare Provider Resources

Symptoms of Creatinine

Causes & Risk Factors for Creatinine

Diagnostic studies for Creatinine

Treatment of Creatinine

Continuing Medical Education (CME)

CME Programs on Creatinine

International

Creatinine en Espanol

Creatinine en Francais

Business

Creatinine in the Marketplace

Patents on Creatinine

Experimental / Informatics

List of terms related to Creatinine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Creatinine is a break-down product of creatine phosphate in muscle, and is usually produced at a fairly constant rate by the body (depending on muscle mass).

Physiology

Creatinine is mainly filtered by the kidney, though a small amount is actively secreted. There is little-to-no tubular reabsorption of creatinine. If the filtering of the kidney is deficient, blood levels rise. As a result, creatinine levels in blood and urine may be used to calculate creatinine clearance (ClCr), which reflects the glomerular filtration rate (GFR). The GFR is clinically important because it is a measurement of renal function. However, in cases of severe renal dysfunction, the creatinine clearance rate will be overestimated because the active secretion of creatinine will account for a larger fraction of the total creatinine cleared.

A more complete estimation of renal function can be made when interpreting the blood (plasma) concentration of creatinine along with that of urea. In the USA, urea concentration is given as blood urea nitrogen (BUN), in mg/dL. In other countries, including those of Europe, urea concentration is measured and quoted in mmol/L.

The ratio of urea to creatinine can indicate other problems besides those intrinsic to the kidney. For example, a urea level raised out of proportion to the creatinine may indicate a pre-renal problem such as dehydration.

Men tend to have higher levels of creatinine because they have more skeletal muscle than women. Vegetarians tend to have lower creatinine levels, because vegetables contain no creatinine.

Diagnostic use

Measuring serum creatinine is a simple test and it is the most commonly used indicator of renal function. A rise in blood creatinine levels is observed only with marked damage to functioning nephrons. Therefore, this test is not suitable for detecting early stage kidney disease. A better estimation of kidney function is given by the creatinine clearance test. Creatinine clearance can be accurately calculated using serum creatinine concentration and some or all of the following variables: sex, age, weight, and race as suggested by the American Diabetes Association without a 24 hour urine collection.[1] Some laboratories will calculate the ClCr if written on the pathology request form; and, the necessary age, sex, and weight are included in the patient information.

Interpretation

In the United States, creatinine is typically reported in mg/dL, while in Canada and Europe μmol/litre may be used. 1 mg/dL of creatinine is 88.4 μmol/l.

The typical reference ranges are 0.5 to 1.0 mg/dL (about 45-90 μmol/l) for women and 0.7 to 1.2 mg/dL (60-110 μmol/l) for men. While a baseline serum creatinine of 2.0 mg/dL (150 μmol/l) may indicate normal kidney function in a male body builder, a serum creatinine of 0.7 mg/dL (60 μmol/l) can indicate significant renal disease in a frail old woman.

More important than absolute creatinine level is the trend of serum creatinine levels over time.

Creatinine levels may increase when ACE inhibitors (ACEI) or angiotensin-II receptor blockers (ARBs) are used in the treatment of chronic heart failure (CHF). Using both ACEI & ARB concomitantly will increase creatinine levels to a greater degree than either of the two drugs would individually. An increase of <30% is to be expected with ACEI or ARB use.

CT Scans

The creatinine level is usually measured before performing a contrast-enhanced Computed tomography (CT) scan. In a small proportion of patients the administration of iodine based contrast can cause kidney damage. This may be more likely or severe in patients with an elevated baseline serum creatinine level and, again, in rare cases may require temporary or permanent dialysis. The risk can be reduced somewhat in higher-risk patients by choosing a low-osmolality contrast medium.

See also

References

  1. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (2005). "Diabetic nephropathy: diagnosis, prevention, and treatment". Diabetes Care. 28 (1): 164–76. PMID 15616252.

Template:SIB

de:Kreatinin it:Creatinina he:קריאטינין nl:Kreatinine no:Kreatinin sv:Kreatinin


Template:WikiDoc Sources